Cambridge Healthtech Institute’s Inaugural
Lead Generation Strategies
Small Molecule Drug Discovery Advances
3 - 4 DECEMBER 2024
There has been an explosion of new tools, technologies and approaches in small molecule drug discovery over the past decade. Targeted protein degradation (TPD) strategies, covalent chemistry, computational applications, DNA-encoded libraries (DEL), and fragment-based ligand discovery (FBLD) have expanded chemical space and/or provided drug leads against ‘difficult’ disease targets such as protein-complexes. Join CHI’s Lead Generation Strategies conference to discuss how to integrate chemical information from various screening strategies and which orthogonal biophysical tools to apply, and when, for hit-to-lead drug discovery steps. This is the first time we bring our popular US-based conference to Europe in order to convene a global contingent of pharma, biotech, and academic scientists focused on discovery chemistry.